Two Billion Dollar Offerings Keep IPO Market Red Hot for the Week Ahead

The initial public offering (IPO) is remaining red hot in the week ahead, with two billion dollar offerings pricing in a double-digit listing week.

Full Truck Alliance Co. Ltd. (NYSE: YMM) plans to raise more than $1.8 billion from 82.5 million shares priced between $17 to $19 each. The Chinese company's freight platform connects shippers with truckers to facilitate shipments across distance ranges, cago weights, and types.

Bright Health Group Inc. (NYSE: BHG) plans to raise more than $1.5 billion from 60 million shares priced between $20 to $23 each. The company seeks to bring a more consumer-centric approach to healthcare to improve consumer experience, with the company currently serving 14 states.

Confluent, Inc. (NASDAQ: CFLT) plans to raise $759 million from 23 million shares priced between $29 to $33 each. The data infrastructure provider is designed to connect all to connect all the applications, systems, and data layers of a company around a real-time central nervous system.

Mister Car Wash, Inc. (NYSE: MCW) plans to raise more than $733 million from 37.5 million shares priced between $15 to $17 each. The car wash brand is the largest in the United States, with 344 locations in 21 states.

Doximity, Inc. (NYSE: DOCS) plans to raise more than $616 million from 23.3 million shares priced between $20 to $23 each. The healthcare network claims to be the leading digital platform for U.S. medical professionals, allowing collaboration and secure coordination of patient care.

Sprinklr, Inc. (NYSE: CXM) plans to raise $418 million from 19 million shares priced in the range of $18 to $20 each. The customer experience software provider helps enterprises create a persistent, unified view of each customers at scale. The company has more than 1,000 customers, including over 50% of the Fortune 100.

First Advantage Corp. (NASDAQ: FA) plans to raise nearly $367 million from about 21.3 million shares priced between $13 to $15 each. The human resources platform provides technology solutions for screening, verifications, safety and compliance related to employees.

Graphite Bio, Inc. (NASDAQ: GRPH) plans to raise $200 million from 12.5 million shares priced between $15 to $17 each. The gene editing biotech's lead candidate has received Investigative New Drug (IND) clearance and expects to begin a Phase 1/2 clinical trial in the second half of this year.

Tencent (OTC: TCEHY) backed Soulgate Inc. (NASDAQ: SSR) plans to raise $185 million from 13.2 million shares offered between $13 to $15 each. The Chinese social networking platform operates the app Soul, which allows users to crease a new identity in a virtual universe to freely create, share, explore, and connect with others.

Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) plans to raise $176 million from 9.8 million shares priced between $17 to $19 each. The oncology-focused biotech plans to submit an IND for one of its selective, orally bioavailable GSPT1-directed MGD molecules in the first half of 2021.

AMTD Digital, Inc. (NYSE: HKD) plans to raise $120 million from 16 million shares priced in the range of $6.80 to $8.20 each. The digital financial services provider operates a comprehensive digital solutions platform in Asia.

Elevation Oncology, Inc. (NASDAQ: ELEV) plans to raise $100 million from 6.3 million shares offered between $15 to $17 each. The clinical stage biotech's lead candidate is expected to result interim analysis data in late 2021/early 2022 and topline data in the first half of 2023.

Alpha Teknova, Inc. (NASDAQ: TKNO) plans to raise $75 million from 5 million shares offered between $14 to $16 each. The biopharmaceutical company providers critical reagents that enable the discovery, reaser, development and production of product such as drug therpare, novel vaccines and molecular diagnostics.

Miromatrix Medical, Inc. (NASDAQ: MIRO) plans to raise $32 million from 4 million shares priced between $7 to $9 each. The company is developing novel technology for bioengineering fully transplantable human organs, with current focus on livers and kidneys.